Acute Intermittent Porphyria Overview
Learn About Acute Intermittent Porphyria
- Acute intermittent porphyria
- AIP
- HMBS deficiency
- Hydroxymethylbilane synthase deficiency
- PBGD deficiency
- Porphobilinogen deaminase deficiency
- Porphyria, Swedish type
- UPS deficiency
- Uroporphyrinogen synthase deficiency
Tmg Northwest Georgia Oncology Center Inc
Bradley Larson is a Hematologist Oncology specialist and a Hematologist in Villa Rica, Georgia. Dr. Larson and is rated as a Distinguished provider by MediFind in the treatment of Acute Intermittent Porphyria. His top areas of expertise are Acute Hepatic Porphyria (AHP), Acute Intermittent Porphyria, Porphyria, Bone Marrow Aspiration, and Endoscopy. Dr. Larson is currently accepting new patients.
University Of Alabama Health Services Foundation, PC
Lisa Willett is an Internal Medicine provider in Birmingham, Alabama. Dr. Willett and is rated as an Advanced provider by MediFind in the treatment of Acute Intermittent Porphyria. Her top areas of expertise are Acute Intermittent Porphyria, Heavy Metal Poisoning, Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), and Hereditary Sensory Neuropathy Type 1 (HSN1). Dr. Willett is currently accepting new patients.
Alabama Cancer Care, LLC
Laura Bunch is an Oncologist and a Hematologist Oncology provider in Gadsden, Alabama. Dr. Bunch and is rated as an Experienced provider by MediFind in the treatment of Acute Intermittent Porphyria. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Paget Disease of the Breast. Dr. Bunch is currently accepting new patients.
Summary: This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porphyria (AIP), an autosomal dominant inborn error of heme biosynthesis.
Summary: The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center